带因者筛检市场规模、份额、成长分析，按检测类型、按疾病类型、按条件、按技术、按最终用户、按地区 - 行业预测，2025 年至 2032 年

2023 年全球带因者筛检市场规模价值为 25 亿美元，预计将从 2024 年的 28.3 亿美元成长到 2032 年的 76.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 13.2%。

随着遗传病患病率不断上升以及对预防性医疗保健的日益重视，全球带因者筛检市场预计将出现成长。基因组技术的进步以及人们对囊肿纤维化、泰-萨克斯病和镰状细胞性贫血等疾病的认识不断提高，预计将在未来几年增加携带者筛检的采用。此外，基因检测管道的改善和优惠的报销政策也为产业相关人员创造了新的机会。然而，缺乏标准化、新兴市场认知度低、结果解释复杂、先进测试技术高成本挑战可能会阻碍市场向 2031 年扩张。整体而言，创新环境已经成熟，但相关人员必须克服这些障碍，才能利用成长机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

携带者筛检市场规模（按测试类型划分）

• 市场概况
• 分子筛检测试
• 生化筛检测试

携带者筛检市场规模（依疾病类型）

• 市场概况
• 囊肿纤维化
• 戴-萨克斯病
• 高雪氏症
• 镰状细胞性贫血症
• 脊髓性肌肉萎缩
• 其他体染色体隐性遗传疾病

携带者筛检市场规模（依疾病状况）

• 市场概况
• 肺部疾病
• 血液系统疾病
• 神经系统疾病
• 其他的

携带者筛检市场规模（依技术划分）

• 市场概况
• DNA序列分析
• 聚合酵素链锁反应
• 微阵列
• 其他的

按最终用户分類的带因者筛检市场规模

• 市场概况
• 医院
• 参考实验室
• 诊所
• 其他的

携带者筛检市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Illumina, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• Natera, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Eurofins Scientific（Luxembourg）
• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Quest Diagnostics Incorporated（USA）
• Invitae Corporation（USA）
• PerkinElmer, Inc.（USA）
• Fulgent Genetics（USA）
• Agilent Technologies, Inc.（USA）
• Genomics England（UK）
• Centogene AG（Germany）
• Integrated DNA Technologies, Inc.（IDT）（USA）
• BGI Genomics（China）
• Ambry Genetics Corporation（USA）
• DNA Genotek Inc.（Canada）
• GeneDx, Inc.（USA）
• MedGenome Labs Pvt. Ltd.（India）

结论和建议

Global Carrier Screening Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 7.63 billion by 2032, growing at a CAGR of 13.2% during the forecast period (2025-2032).

The global carrier screening market is poised for growth, driven by the rising incidence of genetic diseases and an increasing focus on preventive healthcare. Advancements in genomic technologies and heightened awareness of disorders like cystic fibrosis, Tay-Sachs, and sickle cell anemia are expected to enhance the adoption of carrier screening in the coming years. Furthermore, improved accessibility to genetic testing and favorable reimbursement policies present new opportunities for industry players. However, challenges such as a lack of standardization, limited awareness in emerging markets, complexities in result interpretation, and the high costs associated with advanced testing technologies may hinder market progression through 2031. Overall, the landscape is ripe for innovation, but stakeholders must navigate these hurdles to capitalize on growth opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Carrier Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Carrier Screening Market Segments Analysis

Global Carrier Screening Market is segmented by Test Type, Disease Type, Medical Condition, Technology, End User and region. Based on Test Type, the market is segmented into Molecular Screening Test and Biochemical Screening Test. Based on Disease Type, the market is segmented into Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy and Other Autosomal Recessive Genetic Disorders. Based on Medical Condition, the market is segmented into Pulmonary Conditions, Hematological Conditions, Neurological Conditions and Others. Based on Technology, the market is segmented into DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others. Based on End User, the market is segmented into Hospitals, Reference Laboratories, Physician Offices and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Carrier Screening Market

The growing prevalence of genetic disorders acts as a significant catalyst for the Global Carrier Screening market. As more individuals and families become aware of the risks associated with hereditary conditions, the demand for carrier screening tests rises. This heightened awareness drives healthcare providers to prioritize genetic screening as a preventive measure, allowing for informed decision-making and risk assessment. Furthermore, advancements in genetic testing technologies and increasing accessibility to these services contribute to the market's expansion. Ultimately, the high incidence of genetic disorders emphasizes the importance of carrier screening, fostering growth and innovation within the industry.

Restraints in the Global Carrier Screening Market

One of the significant challenges facing the global carrier screening market is the lack of standardization in screening panels. This issue can lead to inconsistencies in test results and interpretations, which may cause confusion among healthcare providers and patients alike. The variability in testing methodologies and panel compositions across different laboratories can hinder the reliability and comparability of results. Additionally, the absence of a unified framework may create barriers to widespread adoption of carrier screening, as stakeholders may be uncertain about the effectiveness and relevance of various screening options. Addressing this lack of standardization is crucial for the market's growth and acceptance.

Market Trends of the Global Carrier Screening Market

The Global Carrier Screening market is witnessing a significant trend towards the integration of digital health solutions, which is poised to enhance patient engagement and streamline the screening process. As companies increasingly adopt digital platforms, the convenience and accessibility of carrier screening services are expected to attract a broader demographic, ultimately driving market growth. This convergence fosters a more personalized healthcare experience, encouraging more individuals to participate in screening initiatives. By leveraging technology, companies can not only expand their operational reach but also refine their service offerings, positioning themselves favorably in a rapidly evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Carrier Screening Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Molecular Screening Test
• Biochemical Screening Test

Global Carrier Screening Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Cystic Fibrosis
• Tay-Sachs
• Gaucher Disease
• Sickle Cell Disease
• Spinal Muscular Atrophy
• Other Autosomal Recessive Genetic Disorders

Global Carrier Screening Market Size by Medical Condition & CAGR (2025-2032)

• Market Overview
• Pulmonary Conditions
• Hematological Conditions
• Neurological Conditions
• Others

Global Carrier Screening Market Size by Technology & CAGR (2025-2032)

• Market Overview
• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Others

Global Carrier Screening Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Reference Laboratories
• Physician Offices and Clinics
• Others

Global Carrier Screening Market Size & CAGR (2025-2032)

• North America (Test Type, Disease Type, Medical Condition, Technology, End User)
  • US
  • Canada
• Europe (Test Type, Disease Type, Medical Condition, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Disease Type, Medical Condition, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Disease Type, Medical Condition, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Disease Type, Medical Condition, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitae Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fulgent Genetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomics England (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centogene AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (IDT) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambry Genetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNA Genotek Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedGenome Labs Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations